CN110934817A - 安神抗过敏乌沉香及其制备方法 - Google Patents
安神抗过敏乌沉香及其制备方法 Download PDFInfo
- Publication number
- CN110934817A CN110934817A CN201911379943.9A CN201911379943A CN110934817A CN 110934817 A CN110934817 A CN 110934817A CN 201911379943 A CN201911379943 A CN 201911379943A CN 110934817 A CN110934817 A CN 110934817A
- Authority
- CN
- China
- Prior art keywords
- parts
- agilawood
- drying
- preparation
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 230000003266 anti-allergic effect Effects 0.000 title claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 28
- 238000001035 drying Methods 0.000 claims abstract description 25
- 238000002156 mixing Methods 0.000 claims abstract description 23
- 239000000843 powder Substances 0.000 claims abstract description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 16
- 238000000227 grinding Methods 0.000 claims abstract description 13
- 235000001361 Styrax officinalis Nutrition 0.000 claims abstract description 11
- 235000019382 gum benzoic Nutrition 0.000 claims abstract description 11
- 238000000465 moulding Methods 0.000 claims abstract description 11
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 9
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims abstract description 9
- 241000790228 Nardostachys jatamansi Species 0.000 claims abstract description 9
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229960003291 chlorphenamine Drugs 0.000 claims abstract description 9
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 9
- 239000012535 impurity Substances 0.000 claims abstract description 9
- 229940068041 phytic acid Drugs 0.000 claims abstract description 9
- 235000002949 phytic acid Nutrition 0.000 claims abstract description 9
- 239000000467 phytic acid Substances 0.000 claims abstract description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 8
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 8
- 239000011718 vitamin C Substances 0.000 claims abstract description 8
- 244000116484 Inula helenium Species 0.000 claims abstract description 5
- 235000002598 Inula helenium Nutrition 0.000 claims abstract description 5
- 238000003825 pressing Methods 0.000 claims abstract description 5
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 claims abstract description 4
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 claims abstract description 3
- 241000158728 Meliaceae Species 0.000 claims abstract 2
- 235000013599 spices Nutrition 0.000 claims description 17
- 210000005036 nerve Anatomy 0.000 claims description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- 206010020751 Hypersensitivity Diseases 0.000 claims description 10
- 241001060310 Styracaceae Species 0.000 claims description 10
- 208000026935 allergic disease Diseases 0.000 claims description 10
- 230000007815 allergy Effects 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 239000003205 fragrance Substances 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 230000002936 tranquilizing effect Effects 0.000 claims description 8
- 238000007873 sieving Methods 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000007605 air drying Methods 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 230000009286 beneficial effect Effects 0.000 claims description 3
- 210000004556 brain Anatomy 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 244000303379 Styrax officinalis Species 0.000 abstract 1
- 239000002304 perfume Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 16
- 239000003814 drug Substances 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 7
- 230000002195 synergetic effect Effects 0.000 description 6
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 5
- DERZBLKQOCDDDZ-JLHYYAGUSA-N cinnarizine Chemical compound C1CN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)CCN1C\C=C\C1=CC=CC=C1 DERZBLKQOCDDDZ-JLHYYAGUSA-N 0.000 description 4
- 229960000876 cinnarizine Drugs 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000000147 hypnotic effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 244000144730 Amygdalus persica Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 235000006040 Prunus persica var persica Nutrition 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 2
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 208000009132 Catalepsy Diseases 0.000 description 2
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 2
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 2
- 235000021353 Lignoceric acid Nutrition 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 244000186561 Swietenia macrophylla Species 0.000 description 2
- 206010047853 Waxy flexibility Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000004531 blood pressure lowering effect Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 239000004021 humic acid Substances 0.000 description 2
- 229940117954 naringenin Drugs 0.000 description 2
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 2
- 235000007625 naringenin Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 241000984061 Aquilaria Species 0.000 description 1
- 241000037488 Coccoloba pubescens Species 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
本发明提出一种安神抗过敏乌沉香及其制作方法，包括将以下各天然香料组分：沉香1‑12份、木香2‑11份、肉桂4‑13份、甘松2‑14份；及各制香原料组分：苏合香3‑12份、红枣粉6‑10份，烨木酸2‑5份、山植酸2‑5份，氯苯吡胺2‑5份，脑益嗪2‑5份，维生素C 2‑5份，大叶桃花心木2‑15份，依次通过除杂、烘干、研磨后混合压制成型的步骤。
Description
技术领域
本发明涉及一种香料的制作技术领域，具体为一种安神抗过敏乌沉香及其制备方法。
背景技术
熏香在古代是非常流行的一种活动，特别是在贵族阶级和文人墨客的生活当中应用的极其广泛，是他们居家养生、陶冶情操必备的日常用品。中药吸入法可追溯到古代。宋代时，中医发展的一个最大贡献是“芳香理气”，以香治病，以香入药，可以说是中药外用的典型。
现有的乌沉香用久了会有头晕的感觉，不能很好的平稳心绪，使用久了，会让人有气腻的感觉，从而使产生心浮气躁的感觉，不能很好的抗焦虑性，安神、失眠、抗脑细胞衰老、调脾胃、抑癌、抗过敏作用不明显。
发明内容
因此，针对上述的问题，本发明提出一种具有安神、调脾胃、抗过敏作用的安神抗过敏乌沉香及其制备方法，以解决上述背景技术中提出的问题。
为实现上述技术问题，本发明采取的解决方案为：安神抗过敏乌沉香，包括天然香料和制香原料，所述天然香料包括以下重量组分：沉香1-12份、木香2-11份、肉桂4-13份、甘松2-14份；所述制香原料包括以下重量组份：苏合香3-12份、红枣粉6-10份，烨木酸2-5份、山植酸2-5份，氯苯吡胺2-5份，脑益嗪2-5份，维生素C 2-5，大叶桃花心木2-15份。
基于同一发明构思本发明还提出一种安神抗过敏乌沉香的制备方法，包括以下步骤：
1）、将1-12份的沉香、2-11份的 木香、4-13份的肉桂、2-14份的甘松；依次进行除杂、烘干后再放入研磨机,研磨1～1.5小时 , 各材料研磨后分别过 50～300 目筛，制得天然香料粉末 ；
2)、将苏合香3-12份、红枣粉6-19份，烨木酸2-5份、山植酸2-5份，氯苯吡胺2-5重量份，脑益嗪2-5重量份，维生素C 2-5份，大叶桃花心木2-15份，依次进行除杂、烘干后再放入研磨机,研磨 1～1.5 小时 , 各材料研磨后分别过 50～300 目筛，制得制香原料粉末 ；
3)：初步调和，将研磨好的制香原料与天然原料放入调和器皿中进行调和，加入有机溶剂进行搅拌，搅拌的环境温度为10-25摄氏度，压强为95-110千帕，搅拌时间为3-7分钟；
4)：进一步调和，向调和器皿中加入成型剂，并进行搅拌，搅拌时间为3-5分钟；
5)：成型，将调和完成的原料使用成型设备，将乌沉香压制成型；
6)：干燥存储，将成型之后的乌沉香采用自然风干的方式晾干，并进行存储。
进一步改进的是：所述步骤1）采用的烘干方式为热气流烘干法。
进一步改进的是：所述步骤3）中采用的有机溶剂为质量分数70％-85％的酒精水溶液，或者质量分数60％-80％的甘油。
进一步改进的是：所述步骤5）中，压制成的形状为圆片状或者长条状。
通过采用前述技术方案，本实用发明的有益效果是：与现有技术相比，本发明的本发明特色在于在配方中加入制香香料，制香香料中的红枣粉中含有黄酮--双- 葡萄糖甙A有镇静、催眠和降压作用，其中被分离出的柚配质C糖甙类有中枢抑制作用，即降低自发运动及刺激反射作用、强直木僵作用，故大枣具有安神、镇静之功。而氯苯吡胺与黄酮--双-葡萄糖甙A催眠及安定化合物一起使用，可加深中枢抑制作用。提高安神安眠效果。
本发明将苏合香、烨木酸、山植酸与氯苯吡胺，脑益嗪及大叶桃花心木组合一起使用具有协同作用，药效优于单独应用时的药效，在安神、抗过敏、调节脾胃方面表现出更为优异的协同作用，能够起到良好的安神、抗过敏作用，同时还能缓解因脑供血不足而导致的头痛 ；且经过不断的实验发现，烨木酸、山植酸有抗癌活性，对人体脏腑功能有一定保护效果。而红枣中含有三萜类化合物及环磷酸腺苷，有较强的抑癌、抗过敏作用。将两者与大叶 桃花心木、氯苯吡胺，脑益嗪一起使用，可降低甚至抵销氯苯吡胺、脑益嗪等药物带来的不良反应，提高药物的生物利用率优点 , 具有相辅相成的协同作用。实践中，该制香香料还以预防老年痴呆症，同时增进血液循环和防止血管阻塞之功效，该配方是本发明人做了近百次实验和配方调整并根据中西药理论进行研制而得，符合 药政法规定。
具体实施方式
现结合具体实施例对本发明进一步说明。
实施例一：
本发明提供一种技术方案：一种安神抗过敏乌沉香，包括天然香料和制香原料，所述天然香料包括以下重量组分：沉香8份、木香7份、肉桂10份、甘松7份；所述制香原料包括以下重量组份：苏合香10份、红枣粉6份，烨木酸2份、山植酸2份，氯苯吡胺2份，脑益嗪2份，维生素C 2份，大叶桃花心木10份。
上述安神抗过敏乌沉香的制备方法，包括以下步骤：
1）、将沉香8份、木香7份、肉桂10份、甘松7份，依次进行除杂、烘干后再放入研磨机,研磨1～1.5小时 , 各材料研磨后分别过 50～300 目筛，制得天然香料粉末 ；
2)、：苏合香10份、红枣粉6份，烨木酸2份、山植酸2份，氯苯吡胺2份，脑益嗪2份，维生素C 2份，大叶桃花心木10份，依次进行除杂、烘干后再放入研磨机,研磨 1～1.5 小时 , 各材料研磨后分别过 50～300 目筛，制得制香原料粉末 ；
3)：初步调和，将研磨好的制香原料与天然原料放入调和器皿中进行调和，加入有机溶剂进行搅拌，搅拌的环境温度为10-25摄氏度，压强为95-110千帕，搅拌时间为3-7分钟；
4)：进一步调和，向调和器皿中加入成型剂，并进行搅拌，搅拌时间为3-5分钟；
5)：成型，将调和完成的原料使用成型设备，将乌沉香压制成圆片状或者长条状；
6)：干燥存储，将成型之后的乌沉香采用自然风干的方式晾干，并进行存储。
所述步骤1采用的烘干方式为热气流烘干法。
所述步骤3中采用的有机溶剂为质量分数70％的酒精水溶液，或者质量分数60％的甘油。
实施例二：
一种安神抗过敏乌沉香，包括天然香料和制香原料，所述天然香料包括以下重量组分：沉香12份、木香11份、肉桂4份、甘松5份；所述制香原料包括以下重量组份：苏合香12份、红 枣粉10份，烨木酸5份、山植酸5份，氯苯吡胺5份，脑益嗪5份，维生素C 5份，大叶桃花心木9份。
上述安神抗过敏乌沉香的制备方法，包括以下步骤：
1）、沉香12份、木香11份、肉桂4份、甘松5份依次进行除杂、烘干后再放入研磨机,研磨1～1.5小时 , 各材料研磨后分别过 50～300 目筛，制得天然香料粉末 ；
2)、：苏合香12份、红枣粉10份，烨木酸5份、山植酸5份，氯苯吡胺5份，脑益嗪5份，维生素C 5份，大叶桃花心木9份依次进行除杂、烘干后再放入研磨机,研磨 1～1.5 小时 , 各材料研磨后分别过 50～300 目筛，制得制香原料粉末 ；
3)：初步调和，将研磨好的制香原料与天然原料放入调和器皿中进行调和，加入有机溶剂进行搅拌，搅拌的环境温度为10-25摄氏度，压强为95-110千帕，搅拌时间为3-7分钟；
4)：进一步调和，向调和器皿中加入成型剂，并进行搅拌，搅拌时间为3-5分钟；
5)：成型，将调和完成的原料使用成型设备，将乌沉香压制成圆片状或者长条状；
6)：干燥存储，将成型之后的乌沉香采用自然风干的方式晾干，并进行存储。
所述步骤1采用的烘干方式为热气流烘干法。
所述步骤3中采用的有机溶剂为质量分数85％的酒精水溶液，或者质量分数80％的甘油。
与现有技术相比，本发明的本发明特色在于在配方中加入制香香料，制香香料中的红枣粉中含有黄酮--双- 葡萄糖甙A有镇静、催眠和降压作用，其中被分离出的柚配质C糖甙类有中枢抑制作用，即降低自发运动及刺激反射作用、强直木僵作用，故大枣具有安神、镇静之功。而氯苯吡胺与黄酮--双- 葡萄糖甙A催眠及安定化合物一起使用，可加深中枢抑制作用。提高安神安眠效果。
本发明将苏合香、烨木酸、山植酸与氯苯吡胺，脑益嗪及大叶桃花心木组合一起使用具有协同作用，药效优于单独应用时的药效，在安神、抗过敏、调节脾胃方面表现出更为优异的协同作用，能够起到良好的安神、抗过敏作用，同时还能缓解因脑供血不足而导致的头痛 ；且经过不断的实验发现，烨木酸、山植酸有抗癌活性，对人体脏腑功能有一定保护效果。而红枣中含有三萜类化合物及环磷酸腺苷，有较强的抑癌、抗过敏作用。将两者与大叶 桃花心木、氯苯吡胺，脑益嗪一起使用，可降低甚至抵销氯苯吡胺、脑益嗪等药物带来的不良反应，提高药物的生物利用率优点 , 具有相辅相成的协同作用。实践中，该制香香料还以预防老年痴呆症，同时增进血液循环和防止血管阻塞之功效，该配方是本发明人做了近百次实验和配方调整并根据中西药理论进行研制而得，符合 药政法规定。
运用本创作所做的修饰、变化，皆属本创作主张的专利范围，而不限于实施例所揭示者。
Claims (5)
1.安神抗过敏乌沉香，包括天然香料和制香原料，其特征在于，所述天然香料包括以下重量组分：沉香1-12份、木香2-11份、肉桂4-13份、甘松2-14份；所述制香原料包括以下重量组份：苏合香3-12份、红枣粉6-10份，烨木酸2-5份、山植酸2-5份，氯苯吡胺2-5份，脑益嗪2-5份，维生素C 2-5份，大叶桃花心木2-15份。
2.一种如权利要求1所述的安神抗过敏乌沉香制备方法，其特征在于，包括以下步骤：
1）、将1-12份的沉香、2-11份的 木香、4-13份的肉桂、2-14份的甘松；依次进行除杂、烘干后再放入研磨机,研磨1～1.5小时 , 各材料研磨后分别过 50～300 目筛，制得天然香料粉末 ；
2)、将苏合香3-12份、红枣粉6-19份，烨木酸2-5份、山植酸2-5份，氯苯吡胺2-5重量份，脑益嗪2-5重量份，维生素C 2-5，大叶桃花心木2-15份，依次进行除杂、烘干后再放入研磨机,研磨 1～1.5 小时 , 各材料研磨后分别过 50～300 目筛，制得制香原料粉末 ；
3)：初步调和，将研磨好的制香原料与天然原料放入调和器皿中进行调和，加入有机溶剂进行搅拌，搅拌的环境温度为10-25摄氏度，压强为95-110千帕，搅拌时间为3-7分钟；
4)：进一步调和，向调和器皿中加入成型剂，并进行搅拌，搅拌时间为3-5分钟；
5)：成型，将调和完成的原料使用成型设备，将乌沉香压制成型；
6)：干燥存储，将成型之后的乌沉香采用自然风干的方式晾干，并进行存储。
3.根据权利要求2所述的一种安神抗过敏乌沉香的制备方法，其特征在于：所述步骤1）采用的烘干方式为热气流烘干法。
4.根据权利要求2所述的一种安神抗过敏乌沉香的制备方法，其特征在于：所述步骤3）中采用的有机溶剂为质量分数70％-85％的酒精水溶液，或者质量分数60％-80％的甘油。
5.根据权利要求2所述的一种安神抗过敏乌沉香的制备方法，其特征在于：所述步骤5）中，压制成的形状为圆片状或者长条状。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911379943.9A CN110934817A (zh) | 2019-12-27 | 2019-12-27 | 安神抗过敏乌沉香及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911379943.9A CN110934817A (zh) | 2019-12-27 | 2019-12-27 | 安神抗过敏乌沉香及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110934817A true CN110934817A (zh) | 2020-03-31 |
Family
ID=69912761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911379943.9A Pending CN110934817A (zh) | 2019-12-27 | 2019-12-27 | 安神抗过敏乌沉香及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110934817A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105833325A (zh) * | 2016-04-07 | 2016-08-10 | 永春县达埔彬达制香厂有限公司 | 一种具有抗过敏功效的天然合香及其制备方法 |
| CN105854057A (zh) * | 2016-04-07 | 2016-08-17 | 永春县达埔彬达制香厂有限公司 | 一种空气净化天然合香及制备方法 |
| CN105879093A (zh) * | 2016-04-07 | 2016-08-24 | 永春县达埔彬达制香厂有限公司 | 一种具有安神助眠的乌沉香及其制备方法 |
| CN107970346A (zh) * | 2017-11-24 | 2018-05-01 | 泉州永春达盛香业股份有限公司 | 一种抗感冒复方熏香及其制备方法 |
-
2019
- 2019-12-27 CN CN201911379943.9A patent/CN110934817A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105833325A (zh) * | 2016-04-07 | 2016-08-10 | 永春县达埔彬达制香厂有限公司 | 一种具有抗过敏功效的天然合香及其制备方法 |
| CN105854057A (zh) * | 2016-04-07 | 2016-08-17 | 永春县达埔彬达制香厂有限公司 | 一种空气净化天然合香及制备方法 |
| CN105879093A (zh) * | 2016-04-07 | 2016-08-24 | 永春县达埔彬达制香厂有限公司 | 一种具有安神助眠的乌沉香及其制备方法 |
| CN107970346A (zh) * | 2017-11-24 | 2018-05-01 | 泉州永春达盛香业股份有限公司 | 一种抗感冒复方熏香及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 陈明岭等: "《皮肤病常用中药药理及临床 第2版》", 31 October 2017, 中国科学技术出版社, pages: 229 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101971894A (zh) | 一种复方牛蒡保健茶 | |
| CN105029417A (zh) | 一种用于改善睡眠的保健食品及其生产工艺 | |
| CN103583757B (zh) | 清凉消暑保健茶的制备方法 | |
| CN105687520A (zh) | 一种抑制脱发、白发产生且促进生发的育发液及配备方法 | |
| KR101551304B1 (ko) | 원지와 석창포를 이용한 건강 기능 식품용 환 및 그 제조 방법 | |
| CN103609778B (zh) | 一种保健普洱茶及其制备方法 | |
| CN107362323A (zh) | 一种改善睡眠的制剂及其制备方法 | |
| CN110432414A (zh) | 一种调节人体机能的霍山石斛组合饮品及其制备方法 | |
| CN107712199A (zh) | 一种养颜花果茶及其制备方法 | |
| CN110664906B (zh) | 一种具有降血糖功能的保健食品的制备方法 | |
| CN105167106A (zh) | 一种具有延缓衰老功效的玫瑰花保健饮料 | |
| CN106490612A (zh) | 一种女性补益膏及制备方法 | |
| CN105267723B (zh) | 一种具有改善睡眠功效的玛咖组方及其制备方法 | |
| KR101914239B1 (ko) | 발모에 유용한 외용제 조성물의 제조방법 | |
| CN110934817A (zh) | 安神抗过敏乌沉香及其制备方法 | |
| CN104694315A (zh) | 一种防衰老葡萄酒及制备方法 | |
| CN110179931B (zh) | 一种养心安神组合物及其制备方法 | |
| CN104222400A (zh) | 醒酒护肝、宁心安神的普洱茶膏及其加工方法 | |
| CN106618128A (zh) | 一种绿色环保线香及其制备方法 | |
| CN104509621A (zh) | 一种暖胃润肺茶及其制备方法 | |
| CN104547285B (zh) | 一种含有沉香叶的、安神助睡眠的组合物 | |
| CN109527140A (zh) | 一种治疗失眠的代用茶及其制备方法 | |
| CN108888720A (zh) | 一种改善睡眠的保健品口服液及制备方法 | |
| CN110314192A (zh) | 注意缺陷多动障碍治疗药物及其制备方法 | |
| CN114796386B (zh) | 一种养颜安神组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zeng Zhibin Inventor after: You Longjie Inventor before: Zeng Zhibin |
|
| CB03 | Change of inventor or designer information | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |